7QEZ | pdb_00007qez

Crystal structure of the SARS-CoV-2 RBD in complex with the ultrapotent antibody CV2.1169 and CR3022


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.89 Å
  • R-Value Free: 
    0.281 (Depositor), 0.292 (DCC) 
  • R-Value Work: 
    0.239 (Depositor), 0.247 (DCC) 
  • R-Value Observed: 
    0.241 (Depositor) 

Starting Models: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7QEZ

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

Planchais, C.Fernandez, I.Bruel, T.de Melo, G.D.Prot, M.Beretta, M.Guardado-Calvo, P.Dufloo, J.Molinos-Albert, L.M.Backovic, M.Chiaravalli, J.Giraud, E.Vesin, B.Conquet, L.Grzelak, L.Planas, D.Staropoli, I.Guivel-Benhassine, F.Hieu, T.Boulle, M.Cervantes-Gonzalez, M.Ungeheuer, M.N.Charneau, P.van der Werf, S.Agou, F.Dimitrov, J.D.Simon-Loriere, E.Bourhy, H.Montagutelli, X.Rey, F.A.Schwartz, O.Mouquet, H.

(2022) J Exp Medicine 219

  • DOI: https://doi.org/10.1084/jem.20220638
  • Primary Citation Related Structures: 
    7QEZ, 7QF0, 7QF1

  • PubMed Abstract: 

    Memory B-cell and antibody responses to the SARS-CoV-2 spike protein contribute to long-term immune protection against severe COVID-19, which can also be prevented by antibody-based interventions. Here, wide SARS-CoV-2 immunoprofiling in Wuhan COVID-19 convalescents combining serological, cellular, and monoclonal antibody explorations revealed humoral immunity coordination. Detailed characterization of a hundred SARS-CoV-2 spike memory B-cell monoclonal antibodies uncovered diversity in their repertoire and antiviral functions. The latter were influenced by the targeted spike region with strong Fc-dependent effectors to the S2 subunit and potent neutralizers to the receptor-binding domain. Amongst those, Cv2.1169 and Cv2.3194 antibodies cross-neutralized SARS-CoV-2 variants of concern, including Omicron BA.1 and BA.2. Cv2.1169, isolated from a mucosa-derived IgA memory B cell demonstrated potency boost as IgA dimers and therapeutic efficacy as IgG antibodies in animal models. Structural data provided mechanistic clues to Cv2.1169 potency and breadth. Thus, potent broadly neutralizing IgA antibodies elicited in mucosal tissues can stem SARS-CoV-2 infection, and Cv2.1169 and Cv2.3194 are prime candidates for COVID-19 prevention and treatment.


  • Organizational Affiliation
    • Institut Pasteur, Université Paris Cité, Laboratory of Humoral Immunology, Paris, France.

Macromolecule Content 

  • Total Structure Weight: 119.8 kDa 
  • Atom Count: 6,633 
  • Modeled Residue Count: 859 
  • Deposited Residue Count: 1,096 
  • Unique protein chains: 5

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Spike protein S1206Severe acute respiratory syndrome coronavirus 2Mutation(s): 1 
Gene Names: S2
UniProt
Find proteins for P0DTC2 (Severe acute respiratory syndrome coronavirus 2)
Explore P0DTC2 
Go to UniProtKB:  P0DTC2
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP0DTC2
Glycosylation
Glycosylation Sites: 1Go to GlyGen: P0DTC2-1
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
CR3022 heavy chainB [auth E]229Homo sapiensMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 3
MoleculeChains  Sequence LengthOrganismDetailsImage
CR3022 light chainC [auth F]221Homo sapiensMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 4
MoleculeChains  Sequence LengthOrganismDetailsImage
CV2.1169 IgA heavy chainD [auth H]225Homo sapiensMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 5
MoleculeChains  Sequence LengthOrganismDetailsImage
CV2.1169 light chainE [auth L]215Homo sapiensMutation(s): 0 

Small Molecules

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.89 Å
  • R-Value Free:  0.281 (Depositor), 0.292 (DCC) 
  • R-Value Work:  0.239 (Depositor), 0.247 (DCC) 
  • R-Value Observed: 0.241 (Depositor) 
Space Group: P 41
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 97.751α = 90
b = 97.751β = 90
c = 164.474γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
Aimlessdata scaling
PDB_EXTRACTdata extraction
XDSdata reduction
PHENIXphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Not funded--

Revision History  (Full details and data files)

  • Version 1.0: 2022-05-18
    Type: Initial release
  • Version 1.1: 2023-06-28
    Changes: Database references
  • Version 1.2: 2024-02-07
    Changes: Data collection, Refinement description
  • Version 1.3: 2024-11-13
    Changes: Structure summary